breast cancer - HER2-positive | breast cancer - HR positive | |
la/mBC - HER2 positive - 1st Line (L1) | la/mBC - HR-positive - 1st line (L1) | |
VEGF(R) inhibitor | ||
bevacizumab based treatment | ||
bevacizumab plus trastuzumab plus docetaxel | AVEREL | |
cediranib plus fulvestrant |